# US 11,079,315 B2 · Spectroscopic measurements with parallel array detector

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,079,315 B2
- Document ID: US11079315B2
- Status: Granted
- Kind: B2
- Application number: 16/404,391
- Filed: 2019-05-06
- Published: 2019-10-24
- Granted: 2021-08-03
- Earliest claimed: 2013-07-18
- Assignees: Nueon Inc.
- Applicants: Nueon Inc.
- Inventors: Robert G. Messerschmidt
- Web page: https://patentgrep.com/patent/US11079315B2

## CPC

- G01N 21/27: using photo-electric detection (G01N21/31 takes precedence){; circuits for computing concentration (logarithmic circuits G06G7/24; photometric circuits in general G01J)}
- A61B 5/0075: {by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence)}
- A61B 5/0261: {using optical means, e.g. infrared light}
- A61B 5/14507: {specially adapted for measuring characteristics of body fluids other than blood (devices for taking samples of body liquids A61B10/0045)}
- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- G01N 21/33: using ultraviolet light (G01N21/39 takes precedence)
- G01N 21/35: using infrared light (G01N21/39 takes precedence)
- G01N 21/65: Raman scattering
- G01N 33/49: Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)}
- A61B 5/208: {adapted to determine urine quantity, e.g. flow, volume}
- A61B 2562/046: in a matrix array
- G01N 2201/06113: Coherent sources; lasers
- G01N 2201/068: Optics, miscellaneous
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A measurement apparatus comprises optical components arranged to provide parallel measurements of a biological sample. The parallel sample measurements provide improved accuracy with lower detection limit thresholds. The parallel measurements may comprise one or more of Raman spectroscopy measurements or infrared spectroscopy measurements. The parallel measurements can be combined with a light source. In many embodiments, the light source comprises one or more wavelengths corresponding to resonance frequencies of one or more molecules of the sample, such as wavelengths of ultraviolet light. The wavelengths of light corresponding to resonance frequencies can provide an increased signal to noise ratio. The parallel array optical configuration can be combined with wavelengths of light corresponding to resonance frequencies in order to provide increased measurement accuracy and detection of metabolites.

## Claims

### Claim 1

A method of measuring a blood sample, the method comprising:
placing the blood sample on a support;
separating the blood sample into a plurality of components;
illuminating the sample with a measurement beam;
measuring a plurality of spectra at a plurality of times with a detector while the blood sample separates; and
identifying from the measurements, using a spatial and temporal profile that indicates separation of blood components over space and time, at least one of the plurality of components.

### Claim 2 (depends on 1)

A method as in claim 1, wherein blood sample comprises one or more of an individual blood cell, a fluid of the blood sample, a hematocrit of the blood sample, or fluids of the hematocrit.

### Claim 3 (depends on 1)

A method as in claim 1, wherein the sample is placed on a chromatography plate and separated with chromatography.

### Claim 4 (depends on 1)

A method as in claim 1, wherein the measurement beam is transmitted through the sample and measured with the detector to determine transmission of the sample.

### Claim 5 (depends on 1)

A method as in claim 1, wherein the measurement beam is emitted from a tunable laser.

### Claim 6 (depends on 1)

A method as in claim 1, wherein the sample is received in an optically transmissive support.

### Claim 7 (depends on 1)

A method as in claim 1, wherein the blood sample is analyzed with an internal reflection mode of an optically transmissive structure.

### Claim 8 (depends on 7)

A method as in claim 7, wherein the blood sample comprises blood cells located on a surface of the optically transmissive structure.

### Claim 9 (depends on 1)

A method as in claim 1, wherein the detector comprises an array detector.

### Claim 10 (depends on 1)

A method as in claim 1, wherein the measurement beam comprises one or more of ultraviolet light, visible light, near infrared light, or infrared light.

### Claim 11 (depends on 1)

A method as in claim 1, wherein the sample separates spatially on a substrate.

### Claim 12 (depends on 1)

A method as in claim 1, wherein a wavelength selector separates wavelengths of light to determine an intensity of specific wavelengths of light.

### Claim 13 (depends on 12)

The method of claim 12, wherein the wavelength selector comprises an optical filter or a grating to separate the wavelengths of light in order to determine the intensity of specific wavelengths of light.
